N/A N=484 Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients
Cancer
Primary: CG Anxiety at 20 Weeks Post-treatment — 52.3; 51.6 T-score
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=343 Mindful Hand Hygiene for Healthcare Workers
Burnout · Mental Health
Primary: The Five Facet Mindfulness Questionnaire (FFMQ) - Post-Intervention — 3.46; 3.35 units on a scale
Phase 2 N=20 Open-Label Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With 22q11.2 Deletion Syndrome (INSPIRE)
22Q11.2 Deletion Syndrome
Primary: Overall Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Treatment-Emergent Serious Adverse Events (SAEs) — 12; 3 Participants
N/A N=39 Healing Dynamics in Human Extraction Sockets Grafted With Bio-Oss Collagen®
Tooth Loss
Primary: Number of Participants That Had an Implant That Survived 3 Years After Implant Placement — 3; 6; 7 participants
Phase 2 N=48 E7 TCR T Cells for Human Papillomavirus-Associated Cancers
Papillomavirus Infections · Cervical Intraepithelial Neoplasia · Carcinoma In Situ
Primary: Phase II: Overall Response Rate Partial Response + Complete Response (PR +CR) — 0; 5 Participants
N/A N=3,083 High Impact E-cigarette Advertisement Features
Vaping Behavior
Primary: Intentions of Using the E-cigarette — 5.27; 5.56; 5.52; 5.70 score on a scale
N/A N=52 Wave Crossover ECP Study for Simplified Therapy
Chronic Stable Angina · Refractory Angina
Primary: Diastolic Augmentation — 0.83; 0.57 Ratio — p=<0.0001
Phase 1 N=148 Leveraging Social Media to Identify and Connect Teens With Eating Disorders to a Mobile Guided Self-Help Mobile Intervention
Eating Disorders
Primary: Eating Disorder Psychopathology — 3.75; 3.93; 3.71; 3.50 EDE-Q Global score — p=0.90
Phase 1 N=25 Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases
Metastatic Malignant Neoplasm in the Brain · Metastatic Melanoma · Mucosal Melanoma
Primary: Dose Limiting Toxicities — 0; 0; 0 Participants
Phase 2 N=42 Dilated Versus Non-Dilated Wavefront Corrections for Patients With Down Syndrome
Down Syndrome · Refractive Errors
Primary: Distance Visual Acuity — 0.41; 0.41; 0.40; 0.43 logMAR — p=0.92
Phase 2 N=41 A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease
Thyroid Eye Disease · Graves Ophthalmopathy · Graves Orbitopathy
Primary: Percentage of Participants Showing a Response in Proptosis Measured Using Hertel Exophthalmometer (≥2 mm Decrease From Baseline) in the Study Eye and Separately in…
Phase 4 N=161 Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms
Attention-Deficit/Hyperactivity Disorder
Primary: Change From Baseline in the Adult ADHD Investigator Symptom Rating Scale (AISRS) Total Score by Visit. — 37.5; -12.3; -14.3; -17.3 score on a scale
N/A N=35 Endometriosis Group Care
Endometriosis · Pelvic Pain
Primary: PROMIS Pain Interference SF 8a — -1.62 t-score
N/A N=1,403 AVANCE-Houston FRAMEWorks Program Evaluation
Adults
Primary: Parenting Behavior Measurement #1 — 3.86; 3.87 score on a scale
N/A N=10 Impact of Passive Heat on Metabolic, Inflammatory and Vascular Health in Persons With Spinal Cord Injury
Spinal Cord Injury · Chronic Inflammation · Glucose Metabolism
Primary: Interleukin-6 — 6.17; 5.30; 6.41 pg/ml